Small molecule photocatalysis enables drug target identification via energy transfer

48Citations
Citations of this article
154Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Over half of new therapeutic approaches fail in clinical trials due to a lack of target validation. As such, the development of new methods to improve and accelerate the identification of cellular targets, broadly known as target ID, remains a fundamental goal in drug discovery. While advances in sequencing and mass spectrometry technologies have revolutionized drug target ID in recent decades, the corresponding chemical-based approaches have not changed in over 50 y. Consigned to outdated stoichiometric activation modes, modern target ID campaigns are regularly confounded by poor signal-to-noise resulting from limited receptor occupancy and low crosslinking yields, especially when targeting low abundance membrane proteins or multiple protein target engagement. Here, we describe a broadly general platform for photocatalytic small molecule target ID, which is founded upon the catalytic amplification of target-tag crosslinking through the continuous generation of high-energy carbene intermediates via visible light-mediated Dexter energy transfer. By decoupling the reactive warhead tag from the small molecule ligand, catalytic signal amplification results in unprecedented levels of target enrichment, enabling the quantitative target and off target ID of several drugs including (+)-JQ1, paclitaxel (Taxol), dasatinib (Sprycel), as well as two G-protein-coupled receptors—ADORA2A and GPR40.

References Powered by Scopus

Multidrug resistance in cancer: Role of ATP-dependent transporters

4963Citations
N/AReaders
Get full text

Selective inhibition of BET bromodomains

3365Citations
N/AReaders
Get full text

A quantitative analysis of kinase inhibitor selectivity

2106Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Visible Light-Induced Reactions of Diazo Compounds and Their Precursors

51Citations
N/AReaders
Get full text

Light-enabled deracemization of cyclopropanes by Al-salen photocatalysis

44Citations
N/AReaders
Get full text

Tracking chromatin state changes using nanoscale photo-proximity labelling

39Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Trowbridge, A. D., Seath, C. P., Rodriguez-Rivera, F. P., Li, B. X., Dul, B. E., Schwaid, A. G., … MacMillan, D. W. C. (2022). Small molecule photocatalysis enables drug target identification via energy transfer. Proceedings of the National Academy of Sciences of the United States of America, 119(34). https://doi.org/10.1073/pnas.2208077119

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 41

59%

Researcher 23

33%

Professor / Associate Prof. 5

7%

Lecturer / Post doc 1

1%

Readers' Discipline

Tooltip

Chemistry 55

76%

Biochemistry, Genetics and Molecular Bi... 10

14%

Pharmacology, Toxicology and Pharmaceut... 5

7%

Agricultural and Biological Sciences 2

3%

Article Metrics

Tooltip
Mentions
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free